Engineered cartilage from human chondrocytes with homozygous knockout of cell cycle inhibitor p21
Preprint
Abstract
Risk factors for the development of osteoarthritis (OA) include genetic background and focal cartilage injury. The search for disease-modifying OA therapies would benefit from a more comprehensive knowledge of the genetic variants that contribute to chondrocyte dysfunction and the barriers to cartilage regeneration. One goal of this study was to establish a system for producing engineered cartilage tissue from genetically-defined primary human chondrocytes through genome editing and single-cell expansion. This process was utilized to investigate the functional effect of bi-allelic knockout of the cell cycle inhibitor p21. The use of ribonucleoprotein (RNP) CRISPR/Cas9 complexes targeting two sites in the coding region of p21 resulted in a high frequency (16%) of colonies with homozygous p21 knockout. Chondrogenic pellet cultures from expanded chondrocytes with complete loss of p21 produced more glycosaminoglycans (GAG) and maintained a higher cell number. Single-cell derived colonies retained the potential for robust matrix production after expansion, allowing for analysis of colony variability from the same population of targeted cells. The effect of enhanced cartilage matrix production in p21 knockout chondrocytes persisted when matrix production from individual colonies was analyzed. Chondrocytes had lower levels of p21 protein with further expansion, and the difference in GAG production with p21 knockout was strongest at early passages. These results support previous findings that implicate p21 as a barrier to cartilage matrix production and regenerative capacity. Further, this work establishes the use of genome-edited human chondrocytes as a promising approach for engineered tissue models containing user-defined gene knockouts and other genetic variants for investigation of OA pathogenesis.Keywords
All Related Versions
- Published version: Tissue Engineering Part A, 26 (7-8), 441.
This publication has 38 references indexed in Scilit:
- Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank dataNature Genetics, 2019
- Meta-analysis of Icelandic and UK data sets identifies missense variants in SMO, IL11, COL11A1 and 13 more new loci associated with osteoarthritisNature Genetics, 2018
- Genome editing for human osteoarthritis – a perspectiveOsteoarthritis and Cartilage, 2017
- Whole-genome sequencing identifies rare genotypes in COMP and CHADL associated with high risk of hip osteoarthritisNature Genetics, 2017
- Tissue engineering for articular cartilage repair – the state of the art2013
- Osteoarthritis: A disease of the joint as an organArthritis & Rheumatism, 2012
- Heritability of articular cartilage regeneration and its association with ear wound healing in miceArthritis & Rheumatism, 2012
- Clinical Cartilage Restoration: Evolution and OverviewClinical Orthopaedics and Related Research, 2011
- Osteoarthritis: an update with relevance for clinical practiceThe Lancet, 2011
- Genetic epidemiology of hip and knee osteoarthritisNature Reviews Rheumatology, 2010